Research Analysts’ Weekly Ratings Changes for Amrize (AMRZ)

Amrize (NYSE: AMRZ) recently received a number of ratings updates from brokerages and research firms:

• 10/19/2026 – Amrize had its price target lowered by Barclays from $55.00 to $40.00. They now have an “equal weight” rating on the stock.
• 10/13/2026 – Amrize had its price target lowered by JPMorgan Chase & Co. from $52.00 to $48.00. They now have a “neutral” rating on the stock.
• 10/12/2026 – Amrize is now covered by Longbow Research. They set a “buy” rating on the stock.
• 10/9/2026 – Amrize was given a new $40.00 price target by DA Davidson.
• 10/9/2026 – Amrize had its price target lowered by Royal Bank Of Canada from $48.00 to $32.00. They now have an “underperform” rating on the stock.
• 10/8/2026 – Amrize was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
• 10/5/2026 – Amrize had its price target lowered by Wells Fargo & Company from $44.00 to $40.00. They now have an “equal weight” rating on the stock.
• 10/5/2026 – Amrize had its price target lowered by Truist Financial from $48.00 to $35.00. They now have a “hold” rating on the stock.
• 10/2/2026 – Amrize had its price target lowered by Citigroup from $58.00 to $50.00. They now have a “buy” rating on the stock.
• 10/1/2026 – Amrize is now covered by Barclays. They set an “equal weight” rating and a $55.00 price target on the stock.
• 10/1/2026 – Amrize is now covered by Barclays. They set an “equal weight” rating and a $55.00 price target on the stock.
• 9/23/2026 – Amrize had its price target lowered by Deutsche Bank Aktiengesellschaft from $64.00 to $56.00. They now have a “buy” rating on the stock.
• 9/22/2026 – Amrize had its price target lowered by UBS Group from $57.00 to $42.00. They now have a “neutral” rating on the stock.
• 9/21/2026 – Amrize had its “outperform” rating reaffirmed by Sanford C. Bernstein. They now have a $60.00 price target on the stock.
• 9/18/2026 – Amrize had its price target lowered by Oppenheimer from $62.00 to $55.00. They now have an “outperform” rating on the stock.
• 9/9/2026 – Amrize had its “equal weight” rating reaffirmed by Wells Fargo & Company. They now have a $44.00 price target on the stock, down from $55.00.
• 9/9/2026 – Amrize was downgraded by Citigroup from “buy” to “cautious”.
• 9/9/2026 – Amrize was downgraded by Wells Fargo & Company from “overweight” to “equal weight”. They now have a $44.00 price target on the stock, down from $55.00.
• 9/2/2026 – Amrize was given a new $40.00 price target by William Blair.
• 9/2/2026 – Amrize was downgraded by JPMorgan Chase & Co. from “overweight” to “neutral”. They now have a $52.00 price target on the stock, down from $57.00.
• 9/2/2026 – Amrize had its “underperform” rating reaffirmed by Bank of America. They now have a $40.00 price target on the stock, down from $50.00.
• 8/31/2026 – Amrize was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.

Amrize Dividend Announcement

The company also recently disclosed a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s dividend payout ratio is currently 5.07%.

Insider Buying and Selling at Amrize

In other news, insider Stephen Clark acquired 5,260 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The stock was acquired at an average cost of $47.31 per share, for a total transaction of $248,850.60. Following the completion of the acquisition, the insider owned 10,637 shares in the company, valued at $503,236.47. This represents a 97.82% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Jan Jenisch bought 26,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 2nd. The stock was purchased at an average cost of $42.47 per share, for a total transaction of $1,104,220.00. Following the transaction, the chief executive officer owned 1,767,000 shares in the company, valued at $75,044,490. The trade was a 1.49% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 48,983 shares of company stock valued at $2,158,755 in the last 90 days. 0.54% of the stock is currently owned by corporate insiders.

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.